OnabotulinumtoxinA for treatment of chronic migraine

Headache

Volumn 51, Issue 6, 2011, Pages 1002-1003

  Markert, Ronald J ^a   Solomon, Glen D ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; ONABOTULINUMTOXIN A; UNCLASSIFIED DRUG;

AGE; BODY MASS; CHI SQUARE TEST; DRUG EFFECT; DRUG EFFICACY; DRUG USE; GENDER; HUMAN; LETTER; METHODOLOGY; PREDICTOR VARIABLE; PRIORITY JOURNAL; TRANSFORMED MIGRAINE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

BOTULINUM TOXINS, TYPE A; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS;

EID: 79958109212     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2011.01898_1.x     Document Type: Letter

References (1)

1. Dodick DW, Turkel CC, Degryse RE, et al,. OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010; 50: 921-936.